产品资料
  首页 >>> 产品目录 >>> **学 >>> 一抗

PPAR alpha抗体

如果您对该产品感兴趣的话,可以
产品名称: PPAR alpha抗体
产品型号:
产品展商: XYbscience
产品文档: 无相关文档

简单介绍

PPAR alpha抗体过氧化物酶体增殖物nongenotoxic致癌物质的本意是通过其与核**受体家族成员相互作用发挥其作用的细胞,称为过氧化物酶体增殖物激活受体(PPARs)。核**受体是配体依赖的细胞内蛋白,通过与相应的配体激活后结合特定的DNA序列来刺激特定基因的转录。研究表明,PPARs的过氧化物酶体增殖物如氯贝酸、降脂、激活和WY-14643,以及一些脂肪酸。这也表明PPARs可以诱导酰基辅酶A氧化酶和细胞色素P450(CYP450 A6 A6转录)通过与特定的反应元件相互作用。PPARα是由包括亚油酸、花生四烯酸和油酸在内的游离脂肪酸激活的。PPAR alpha抗体通过这一机制诱导过氧化物酶体导致血甘油三酯水平的降低。PPARα主要表达于骨骼肌、心脏、肝脏和肾脏,被认为调节许多与脂肪酸β氧化有关的基因。


PPAR alpha抗体  的详细介绍

PPAR alpha抗体特异性结合抗原:抗体本身不能直接溶解或杀伤带有特异抗原的靶细胞,通常需要补体或吞噬细胞等共同发挥效应以**病原微生物或导致病理损伤。然而,抗体可通过与病毒或**的特异性结合,直接发挥中和病毒的作用。

产品编号xy- 23398R

英文名称PPAR alpha

中文名称α型-过氧化酶活化增生受体抗体

别    名hPPAR; MGC2237; MGC2452; NR1C1; Nuclear receptor subfamily 1 group C member 1; Peroxisome Proliferator Activated Receptor alpha; PPAR; PPARA; OTTHUMP00000197740; OTTHUMP00000197741; Peroxisome proliferator-activated receptor alpha; PPAR-alpha; PPARA_HUMAN; PPARalpha.  PPAR α; PPAR-α; PPARα;

说 明 书100ul  200ul

研究领域肿瘤  **学  信号转导  转录调节因子  激酶和磷酸酶  

抗体来源Rabbit

克隆类型Polyclonal

PPAR alpha抗体交叉反应 Human, Mouse, Rat, Chicken, Dog, Pig, Horse, Rabbit, Sheep,

产品应用WB=1:500-2000 ELISA=1:500-1000 IHC-P=1:400-800 IHC-F=1:400-800 ICC=1:100-500 IF=1:100-500 (石蜡切片需做抗原修复)

not yet tested in other applications.

optimal dilutions/concentrations should be determined by the end user.

分 子 量51kDa

细胞定位细胞核

性    状Lyophilized or Liquid

浓    度1mg/1ml

免 疫 原KLH conjugated synthetic peptide derived from human PPAR alpha:181-280/468 2<7>3

亚    型IgG

纯化方法affinity purified by Protein A

储 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

PPAR alpha抗体保存条件Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.

PubMedPubMed

产品介绍background:

Peroxisome proliferators are nongenotoxic carcinogens which are purported to exert their effect on cells through their interaction with members of the nuclear hormone receptor family, termed Peroxisome Proliferator Activated Receptors (PPARs). Nuclear hormone receptors are ligand dependent intracellular proteins that stimulate transcription of specific genes by binding to specific DNA sequences following activation by the appropriate ligand. Studies indicate that PPARs are activated by peroxisome proliferators such as clofibric acid, nafenopin, and WY-14,643, as well as by some fatty acids. It has also been shown that PPARs can induce transcription of acyl coenzyme A oxidase and cytochrome P450 A6 (CYP450 A6) through interaction with specific response elements. PPAR alpha is activated by free fatty acids including linoleic, arachidonic, and oleic acids. Induction of peroxisomes by this mechanism leads to a reduction in blood triglyceride levels. PPAR alpha is expressed mainly in skeletal muscle, heart, liver, and kidney and is thought to regulate many genes involved in the beta-oxidation of fatty acids. Activation of rat liver PPAR alpha has been shown to suppress hepatocyte apoptosis. PPAR alpha, like several other nuclear hormone receptors, heterodimerizes with retinoic X receptor (RXR) alpha to form a transcriptionally competent complex.


Function:

Ligand-activated transcription factor. Key regulator of lipid metabolism. Activated by the endogenous ligand 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-GPC). Activated by oleylethanolamide, a naturally occurring lipid that regulates satiety (By similarity). Receptor for peroxisome proliferators such as hypolipidemic drugs and fatty acids. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as transcription activator for the ACOX1 and P450 genes. Transactivation activity requires heterodimerization with RXRA and is antagonized by NR2C2.


Subunit:

Heterodimer; with RXRA. This heterodimerization is required for DNA binding and transactivation activity. Interacts with AKAP13, LPIN1 and PRDM16. Also interacts with PPARBP coactivator in vitro. Interacts with CITED2; the interaction stimulates its transcriptional activity. Interacts with NCOA3 and NCOA6 coactivators. Interacts with ASXL1 AND ASXL2.


Subcellular Location:

Nucleus.


Tissue Specificity:

Skeletal muscle, liver, heart and kidney.


Similarity:

Belongs to the nuclear hormone receptor family. NR1 subfamily.

Contains 1 nuclear receptor DNA-binding domain.


SWISS:

Q07869


Gene ID:

5465

PPAR alpha抗体antibody, Ab)是由效应B细胞(效应**B细胞)分泌,机体用于抵御外来物质,如病毒,**等抗原,结构呈“Y”字型的球状蛋白质,仅仅存在于脊椎动物的血液和B**细胞膜表面。凡是能够跟抗体结合的物质,均被称作抗原,因此对于抗抗体(能够结合抗体的抗体)来说,抗体本身也是一种抗原物质。

   QQ图片20171030091318

PPAR alpha抗体普通抗体重链和轻链的结构

重链结构:普通的**球蛋白具有2条重链(H链),分子量约为50kD,有μ、δ、γ、ε和α五种重链亚型,对应的**球蛋白名称分别为IgMIgGIgAIgDIgE

轻链结构:  普通**球蛋白具有2条轻链(L链),分子质量约25kDa,有κ链和λ链两种亚型,这两种轻链决定了Ig的亚型类别(IgG1IgG2IgG3IgG4)。一个天然的Ig分子两条轻链总是相同的,但在同一个体内可存在分别带有κ或λ链的抗体分子。不同种属生物体内两型轻链的比例不同,正常人血清**球蛋白κ链:λ链约为21,而在小鼠的比例为201

2.2抗体Fab段和Fc

IgG经木瓜蛋白酶酶切后裂解为2个完全相同的Fab段和1Fc,每个Fab段都为单价,可与抗原结合但不会再发生凝集反应;经胃蛋白酶酶切后裂解为1个完整F(ab)2片段和碎片化的Fc片段,F(ab)2片段为双价,可同时结合两个抗原表位。Fab段为抗原结合片段(fragment of antigen bindingFab),相当于抗体分子的两个臂,由一个完整的轻链和重链的VHCH1结构域组成。Fc段为可结晶段(fragment crystallizableFc)相当于IgCH2CH3结构域,是Ig与效应分子或者细胞相互作用的部位。Fab段包含完整的可变区,以及恒定区的CH1区域。Fc段仅指Ig恒定区CH2CH3的区域,相当于Y字结构下面那一部分。

合格 合格 caspase-9 p10 半胱胺酸蛋白酶蛋白9-p10抗体 
合格 hnRNP M 异质性核糖核蛋白M抗体
合格 OSTM1 骨硬化病相关跨膜蛋白1抗体
合格 Reg3a precursor 胰岛β细胞生长因子抗体
合格 合格 MSX1 MSH同源蛋白1样蛋白抗体
合格 MtTF1/TFAM 线粒体转录因子1抗体
合格 Calcium Sensing Receptor 钙敏感受体1抗体
合格 合格 TPP1 细胞生长抑制基因1蛋白抗体
合格 合格 Vimentin 波形蛋白抗体
合格 合格 TRPV5 辣椒素受体5抗体
合格 合格 Nucleolin/C23 核仁蛋白C23抗体
合格 EP4 前列腺素E受体蛋白4抗体
合格 CLEC 4E C型凝集素4家族E抗体
合格 合格 GABR B3 G氨基丁酸受体3抗体
合格 TRAF4 肿瘤坏死因子受体相关蛋白4抗体
合格 合格 3-Nitrotyrosine 硝基酪氨酸抗体
合格 Desmuslin 中间丝蛋白β-synemin抗体
合格 non-muscle Myosin IIA 非平滑肌肌球蛋白2A抗体
合格 Phospho-NMDAR2B (Tyr1474) 磷酸化谷氨酸受体2B抗体
合格 FSIP1 纤维性鞘结合蛋白1抗体
合格 Arginase 1 精氨酸酶1抗体
合格 DOK5 胞浆接头蛋白Dok5抗体
合格 Etv5 转录因子Ets差异基因5抗体
合格 phospho-PKC Epsilon(Ser729) 磷酸化蛋白激酶C/p-PKC ε抗体
 


产品留言
标题
联系人
联系电话
内容
验证码
点击换一张
注:1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!